908 Devices Inc (MASS)
6.62
-0.90
(-11.97%)
USD |
NASDAQ |
Mar 20, 16:00
6.93
+0.31
(+4.68%)
After-Hours: 18:40
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 212.15M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -60.87% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.446 |
| Price to Book Value | 1.113 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0787 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
News
Headline
Wire
Time (ET)
MT Newswires
03/07 07:00
Yahoo
03/07 07:00
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 05/10/2023* | 08:30 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
| 05/10/2023* | -- | Results | Q1 2023 | -- | -0.34 | -- | |
| 03/07/2023 | 08:30 EST | Earnings Call | Q4 2022 | -- | -- | -- | |
| 03/07/2023 | -- | Results | Q4 2022 | -0.31 | -0.24 | -27.05% | |
| 11/14/2022 | 08:30 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
| 11/14/2022 | -- | Results | Q3 2022 | -0.20 | -0.21 | 5.88% | |
| 08/09/2022 | 08:30 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 08/09/2022 | -- | Results | Q2 2022 | -0.26 | -0.26 | 0.00% |
*Estimated Date/Time
Earnings
Profile
Edit
| 908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. |
| URL | https://www.908devices.com |
| Investor Relations URL | https://ir.908devices.com/ |
| HQ State/Province | Massachusetts |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Small Cap/Value |
| Next Earnings Release | May. 10, 2023 (est.) |
| Last Earnings Release | Mar. 07, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | -- |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.00 |
| Yield to Sector | 0.00 |
| Yield to Industry | 0.00 |
| Last Dividend Amt. | -- |
| Dividend Frequency | -- |
| Last Ex-Dividend Date | -- |
| Yield (TTM) | 0% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 17, 2023.
Fundamentals
| Revenue (TTM) | 46.85M |
| Total Expenses (TTM) | 82.23M |
| Net Income (TTM) | -33.56M |
| Total Assets (Quarterly) | 242.59M |
| Total Liabilities (Quarterly) | 51.99M |
| Shareholders Equity (Quarterly) | 190.60M |
| Cash from Operations (TTM) | -20.93M |
| Cash from Investing (TTM) | -15.81M |
| Cash from Financing (TTM) | 1.179M |
Ratings
Profile
Edit
| 908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. |
| URL | https://www.908devices.com |
| Investor Relations URL | https://ir.908devices.com/ |
| HQ State/Province | Massachusetts |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Small Cap/Value |
| Next Earnings Release | May. 10, 2023 (est.) |
| Last Earnings Release | Mar. 07, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Nasdaq | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| MASS Tweets |